Oricula: UW spin-out Oricula Therapeutics raises cash to sell medicine that prevents hearing loss

Oricula Therapeutics, a startup spun out of the University of Washington, has raised $122,000 to commercialize medicine that can help prevent hearing loss. Founded in 2013, Seattle-based Oricula grew out of research done at the UW that uncovered ways to help patients maintain good hearing after taking antibiotics for serious infections. The startup has licensed the intellectual property from the UW and will use the fresh funding, which comes from the company’s founders and one angel investor, to move its research into the real world. Oricula said its product will be the first FDA-approved medicine that can protect the inner ear from... Read More on GeekWire